Gil Block

Dr. Block has 33 years of experience in the pharma/biotech fields leading clinical development of drugs for a broad range of neurological indications, including Alzheimer’s Disease. He was at Merck for 14 years as Senior Director and Head of Clinical Neuropharmacology. Later he was the Executive Director, US Drug Development/Global Medicine & Science, at AstraZeneca. He has expertise ranging from preclinical and clinical translation, clinic development in all phases, to marketing approval.